Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TengFuJiangYa Tablets for grade 1 hypertension with liver yang hyperactivity syndrome
ChiCTR-IIR-17011940Phase 3Not yet recruiting
- Sponsor
- Shandong University of Traditional Chinese Medicine
- Start
- Jul 2017
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of TengFuJiangYa in essential hypertension (2 arms), sponsored by Shandong University of Traditional Chinese Medicine. Primary endpoints: Blood pressure and TCM syndrome score. Planned start Jul 2017; status: not yet recruiting.
02
Drugs
TengFuJiangYa
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-IIR-17011940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17011940.